Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AbbVie to Invest $195M in Chicago Manufacturing Plant | Contract Pharma

What are you searching for?

Sign in
Breaking News

AbbVie to Invest $195M in Chicago Manufacturing Plant

Will expand domestic active pharmaceutical ingredient (API) production in the U.S.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma
Abbvie

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S.

The new North Chicago API facility will expand AbbVie’s chemical synthesis capabilities in the U.S., supporting domestic production of current and next-generation neuroscience, immunology and oncology medicines.

This expansion is part of AbbVie’s previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical manufacturing capabilities and capacity.

“Over the next decade, AbbVie will expand production of API, drug product, peptides and medical devices in the U.S. to support future medical breakthroughs,” said Robert A. Michael, Chairman and CEO, AbbVie. “This is an important step to maintain U.S. leadership in pharmaceutical innovation and deliver next-generation medicines that make a remarkable impact on patients’ lives.”

Construction of the new North Chicago API facility will begin in fall 2025, with the site projected to be fully operational in 2027.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics